Isolation and Structural Characterization of Bioactive Compounds from Alpinia purpurata Targeting Prostate Cancer Receptors CXCR4 and PTEN: A Molecular Docking Approach
Natural and Life Sciences Communications · 23.03.2026 · 25 (3)
DOI: 10.12982/nlsc.2026.056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Natural and Life Sciences Communications, online erschienen am 23.03.2026. Verfasst von Anusooriya Palanirajan und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Prostate cancer (PCA) is the most prevalent one among men all-inclusive, affecting men in over 112 countries. It is expected to upsurge from 1,400,000 instances in 2020 to 2,900,000 incidents by 2040. The purpose of the present investigation was to evaluate the anticancer properties of bioactive components extracted from Alpinia purpurata (A. purpurata) leaf extract with the C-X-C chemokine receptor type 4 (CXCR4) and phosphatase and tensin homolog (PTEN) receptor protein targets in comparison to the conventional drug Finasteride. Bioactive chemicals from this plant have not yet been identified as a treatment for PCA. The ethyl acetate extract of A. purpurata was subjected to fractionation using column chromatography and characterization using spectroscopic analysis followed by molecular docking were carried out by Computational methods. Pentatriacontanoic acid, Nonacosanol and triacontanol were the compounds isolated and characterized from the ethyl acetate extract of A. purpurata. All the three compounds used in this study qualify to be drug candidates according to the Absorption, Distribution, Metabolism, and Excretion (ADME) properties predictions and of these pentatriacontanoic acid, 1-nonacosanol and triacontanol show good anticancer potential. The three isolated compounds, pentatriacontanoic acid might render strong anti-tumour effects. Ultimately, it can be stated that pentatriacontanoic acid has the potential to be an effective treatment for PCA.
Zitieren
APA
Palanirajan, A., Kannappan, P., Raju, M. V., Chandrasekaran, M. K., Ahalliya, R. M., Jothinathan, M. K. D., & Kanniappan, G. V. (2026). Isolation and Structural Characterization of Bioactive Compounds from Alpinia purpurata Targeting Prostate Cancer Receptors CXCR4 and PTEN: A Molecular Docking Approach. Natural and Life Sciences Communications, 25(3). https://doi.org/10.12982/nlsc.2026.056
Vancouver
Palanirajan A, Kannappan P, Raju MV, Chandrasekaran MK, Ahalliya RM, Jothinathan MKD, et al. Isolation and Structural Characterization of Bioactive Compounds from Alpinia purpurata Targeting Prostate Cancer Receptors CXCR4 and PTEN: A Molecular Docking Approach. Natural and Life Sciences Communications. 2026;25(3). doi:10.12982/nlsc.2026.056
BibTeX
@article{Palanirajan2026,
author = {Palanirajan, Anusooriya and Kannappan, Poornima and Raju, Manikandan Vani and Chandrasekaran, Meenakshi Kaniyur and Ahalliya, Rathi Muthaiyan and Jothinathan, Mukesh Kumar Dharmalingam and Kanniappan, Gopalakrishnan Velliyur},
title = {Isolation and Structural Characterization of Bioactive Compounds from Alpinia purpurata Targeting Prostate Cancer Receptors CXCR4 and PTEN: A Molecular Docking Approach},
journal = {Natural and Life Sciences Communications},
year = {2026},
volume = {25},
number = {3},
doi = {10.12982/nlsc.2026.056}
}
EUVIMED